retatrutide europe Cyprus Peptides Retatrutide 10mg – Triple Agonist

Novo Nordisk is awaiting an FDA decision for their fixed-dose combination of the amylin receptor agonist, cagrilintide, and the GLP-1, semaglutide

Management strategies: Eat smaller, more frequent meals Avoid high-fat, greasy, or heavily spiced foods initially Stay hydrated For constipation (common): increase fiber gradually, drink more water, consider magnesium supplement Ginger or peppermint tea for nausea Dont lie down immediately after eating (helps with reflux) Under-eating risk (serious for women over 40): The appetite suppression can be so strong that some women struggle to eat enough protein and calories to support muscle maintenance and basic metabolic function

Think Greek yogurt, cottage cheese, eggs, chicken soup, rice bowls, turkey slices, tuna, protein shakes, and soft potatoes

Dehydration Risk Increases GLP-1 users often: eat less drink less feel less thirsty Alcohol: increases fluid loss increases electrolyte imbalance This can lead to: headaches fatigue constipation (already common on GLP-1s) dizziness Hydration becomes much more important

The other is still working through Phase 3 trials with regulatory submission likely a year or more away

Participants lost an average of 10-15% of their body weight over the course of a year, and many showed improvements in blood pressure and cholesterol levels